|Bid||51.47 x 100|
|Ask||51.55 x 100|
|Day's Range||50.79 - 51.72|
|52 Week Range||34.58 - 65.91|
|PE Ratio (TTM)||44.11|
|Earnings Date||Nov 1, 2017 - Nov 6, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||55.30|
Several recent FDA product-approvals boost investors' trust in Edwards Lifesciences' (EW) stock.
Chemed (CHE) bolsters investor's confidence with continued strength in Roto-Rooter business.
BioTelemetry's (BEAT) consistent efforts in product innovation through research and development buoy optimism. Also, the recent acquisition instills confidence in investors.